Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
10.3350/cmh.2024.0394
Author:
Young Eun CHON
1
;
Dong Yun KIM
;
Hong Jae CHON
;
Do Young KIM
Author Information
1. Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
Publication Type:Correspondence
From:Clinical and Molecular Hepatology
2024;30(4):1005-1008